Form 4: Repare Therapeutics EVP, CHIEF MEDICAL OFFICER Maria Koehler Reports Sale of Shares for Tax Obligations
SEC Form 4 Filing
Maria Koehler, EVP, CHIEF MEDICAL OFFICER of Repare Therapeutics Inc., reports selling 3,596 common shares to cover tax obligations related to vesting restricted stock units.
Summary
- On March 12, 2025, Maria Koehler, the EVP, CHIEF MEDICAL OFFICER of Repare Therapeutics Inc. (RPTX), sold 3,596 common shares.
- The sale was executed at a price of $1.14 per share.
- This transaction was to satisfy the reporting person's tax withholding obligation in connection with the vesting and settlement of restricted stock units.
- Following the transaction, Koehler directly owns 227,813 common shares of Repare Therapeutics Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations, with no indication of positive or negative implications for the company's performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders buy or sell their company's stock. This provides transparency to the market regarding the transactions of individuals with access to non-public information.
Stakeholder Impact
- The sale of shares by an executive could be perceived neutrally by shareholders as it is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of transaction: Maria Koehler sold 3,596 common shares. |
| 03/14/2025 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.